YERVOY (ipilimumab) injection
Product Brand Name: YERVOY. API Name: ipilimumab. YERVOY (ipilimumab) injection is indicated to treat colorectal cancer, esophageal cancer, hepatocellular carcinoma (a type of liver cancer), malignant pleural mesothelioma, melanoma, non-small cell lung cancer, and renal cell carcinoma (a type of kidney cancer).
- Active ingredient: ipilimumab. Inactive ingredients: diethylene triamine pentaacetic acid (DTPA), mannitol, polysorbate 80, sodium chloride, tris hydrochloride, and Water for Injection, USP
- API – ipilimumab
- Brand name – YERVOY (ipilimumab) injection, for intravenous use Initial U.S. Approval: 2011
- Strength – • Injection: 50 mg/10 mL (5 mg/mL)
• Injection: 200 mg/40 mL (5 mg/mL)
For Best Price: To know the best price of the product available with Lucknow Speciality Pharma call at Contact No. 9760014849, 9555306364, 9794360370, 9140551027 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
About Us
Lucknow Speciality Pharma is a registered Pharmaceutica Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Get Access To YERVOY (ipilimumab) injection
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Nepal
Ipilimumab was approved by the U.S. Food and Drug Administration (FDA) in March 2011, to treat people with late-stage melanoma that has spread or cannot be removed by surgery. It was later approved by the US FDA on October 28, 2015, for stage 3 patients as adjuvant therapy. On February 1, 2012, Health Canada approved ipilimumab for "treatment of unresectable or metastatic melanoma in patients who have failed or do not tolerate other systemic therapy for advanced disease. Ipilimumab was approved in the European Union (EU), for second line treatment of metastatic melanoma in November 2012.
ipilimumab is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “YERVOY (ipilimumab) injection“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Medicines Delivered
We have supplied to following cities in India-
Lucknow Speciality Pharma has delivered “YERVOY (ipilimumab) injection“ in Kanpur, Lucknow, Ghaziabad, Agra, Meerut, Varanasi, Prayagraj, Bareilly, Aligarh, Moradabad, Saharanpur, Gorakhpur, Noida, Firozabad, Jhansi, Muzaffarnagar, Mathura-Vrindavan, Ayodhya, Rampur, Shahjahanpur, Farrukhabad-Fatehgarh, Budaun, Maunath, Hapur, Etawah, Mirzapur-Vindhyachal, Bulandshahr, Sambhal, Amroha, Hardoi, Fatehpur, Raebareli, Orai, Sitapur, Bahraich, Modinagar, Unnao, Jaunpur, Lakhimpur, Hathras, Banda, Pilibhit, Barabanki, Khurja, Gonda, Mainpuri, Lalitpur, Etah, Deoria, Badaun, Ghazipur, Sultanpur, Azamgarh, Bijnor, Sahaswan, Basti, Chandausi, Akbarpur, Ballia, Ambedkar Nagar, Greater Noida, Shikohabad, Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga, Siwan, Sasaram, Hajipur, Burdwan, Kolkata, Kharagpur, Asansol, Haldia, Siliguri, Howrah, Imphal, Guwahati and Agartala and Nepal.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
9555306364, 9794360370, 9140551027
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
